Ed Dougherty

Title: Ed Dougherty: Innovator in Glioma Classification

Introduction

Ed Dougherty, based in College Station, TX, is an accomplished inventor known for his significant contributions to the field of medical diagnostics. With a focus on glioma classification, he holds a notable patent that enhances the accuracy of identifying various types of brain tumors.

Latest Patents

Dougherty's patent titled "Gene sets for glioma classification" has introduced a range of gene markers whose expressions are altered in different gliomas. This innovation allows for precise classification of gliomas into categories such as glioblastoma multiforme (GM), anaplastic astrocytoma (AA), anaplastic oligodendroglioma (AO), and oligodendroglioma (OL). The diagnostic process can be performed on nucleic acids, for example, through DNA microarrays, or on proteins using immunologic techniques. The patent also outlines methods of therapy that could benefit patients affected by these tumors.

Career Highlights

Dougherty's professional journey includes significant roles at the University of Texas System and Texas A&M University System. His work has contributed to advancing the understanding of gliomas and improving diagnostic methodologies in the medical community.

Collaborations

Throughout his career, Ed Dougherty has collaborated with notable individuals in the field, including Wei Zhang and Greg Fuller. These partnerships have likely enriched his research and led to innovative advancements in glioma classification and therapy.

Conclusion

Ed Dougherty's commitment to innovation in the realm of glioma classification highlights the importance of genetic research in improving medical diagnostics. His patented technology not only promises greater accuracy in diagnoses but also paves the way for potential therapeutic options, emphasizing the vital role of inventors in the healthcare landscape.